Home/Rare Diseases/Lennox-Gastaut Syndrome

Neurological & Neuromuscular

Lennox-Gastaut Syndrome

Also called LGS, Petit Mal Variant

Lennox-Gastaut Syndrome represents one of the most severe and intractable childhood epilepsies, often emerging from or following infantile spasms (West Syndrome). The characteristic EEG pattern shows slow (1-2.

View active trialsMatch me to a trial

About Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome represents one of the most severe and intractable childhood epilepsies, often emerging from or following infantile spasms (West Syndrome). The characteristic EEG pattern shows slow (1-2.5 Hz) spike-and-wave activity, particularly evident during sleep. The syndrome is marked by multiple seizure types, with tonic seizures (brief stiffening episodes) being particularly characteristic, often occurring in clusters, especially during sleep. Atonic seizures (drop attacks) can lead to sudden falls and injuries, necessitating protective headgear and environmental modifications. Atypical absence seizures differ from typical absence seizures in their slower onset and offset. The intellectual disability is usually moderate to severe, with developmental progress typically slowing or reversing after syndrome onset. Behavioral comorbidities including autism spectrum features, anxiety, and sleep disturbances are common. Status epilepticus, with continuous or rapidly recurring seizures, represents a medical emergency.

Common Symptoms

  • Multiple seizure types: tonic-clonic, atonic (drop attacks), atypical absence, and focal seizures
  • Frequent clusters of seizures, sometimes hundreds per day
  • Intellectual disability and developmental regression
  • Speech and language delays
  • Behavioral disturbances including hyperactivity, aggression, and mood problems
  • Status epilepticus (prolonged or repeated seizures)

Who It Affects

Lennox-Gastaut Syndrome typically manifests between ages 1 and 8 years, with peak onset between 3 and 5 years. It affects males and females equally and occurs across all ethnic and racial groups. While some cases are symptomatic (caused by identified brain abnormalities), many are cryptogenic or idiopathic with no clear underlying cause. Previous history of infantile spasms increases risk.

Getting Involved in Clinical Trials

Treatment of Lennox-Gastaut Syndrome remains challenging, but recent FDA approvals of medications like cannabidiol and topiramate have improved outcomes. Clinical trials continue investigating novel antiepileptic drugs, gene therapy approaches, and neuromodulation strategies. Vagus nerve stimulation and ketogenic diet therapy represent non-pharmacological options with documented benefit. Specialized epilepsy centers can provide comprehensive evaluation and information about available trials. The Epilepsy Foundation and Lennox-Gastaut Syndrome specific organizations maintain updated trial registries.

Trusted Sources

Active Clinical Trials for Lennox-Gastaut Syndrome

Finding trials for Lennox-Gastaut Syndrome...

Related Neurological & Neuromuscular Conditions

Neurological & Neuromuscular

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is an X-linked genetic disorder causing progressive muscle weakness and degeneration, beginn...

Neurological & Neuromuscular

Spinal Muscular Atrophy

Spinal muscular atrophy is an autosomal recessive genetic disorder affecting motor neurons in the spinal cord, causing p...

Neurological & Neuromuscular

Myasthenia Gravis

Myasthenia gravis is a chronic autoimmune neuromuscular disorder causing muscle weakness and rapid fatigue. Antibodies a...